Colchicine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 12:52, April 12, 2022 by Notjusttired (talk | contribs) (Text replacement - "|last2=|first2=|authorlink2=|date" to "|date")

Colchicine is an anti-inflammatory that also acts as an immunomodulator and is used for a number of different illnesses including gout, recurrent pericarditis, and familial Mediterranean fever.[1][2][3] Colchicine is also sold under the brand names Colcrys, Mitigare, Gloperba.[3]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Colchicine | COVID-19 Treatment Guidelines". National Institutes of Health. Retrieved January 3, 2022.
  2. ↑ "Colchicine". drugs.com. Retrieved January 3, 2022.
  3. ↑ 3.0 3.1 "Colchicine: MedlinePlus Drug Information". MedlinePlus. Retrieved January 3, 2022.

immunomodulator An immunomodulator is a substance that affects the functioning of the immune system

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

Retrieved from "https://me-pedia.org/w/index.php?title=Colchicine&oldid=98439"